Clinical Trial Update: Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol [Phase 2]

View source ↗

Summary

Phase 2 trial update for Triferic IRIDA protocol shows termination with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron-refractory Iron-deficiency Anemia

Drugs mentioned

• Triferic IRIDA (iron therapy)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: Iron-Refractory Iron-Deficiency Anemia | Phase 2 | Status: TERMINATED | Results posted: 2020-09-02